Structural features of glutamate-based lipidic materials for small interfering RNA delivery system

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 3, 2009, Pages 739-750

  Kusumoto, Ken Ichi ^a  

^a FUKUOKA INDUSTRIAL TECHNOLOGY CENTER   (Japan)

Author keywords

Delivery; Lipidic material; Nonviral carrier; Sirna; Structural feature

Indexed keywords

DELIVERY; LIPIDIC MATERIAL; NONVIRAL CARRIER; SIRNA; STRUCTURAL FEATURE;

ETHYLENE; HYDROPHOBICITY; NUCLEIC ACIDS; RNA; THERMOANALYSIS;

MATERIALS;

GLUTAMIC ACID; LIPID; LIPID DIDODECYLACETYLGLUTAMATETRIMETHYLAMMONIUM; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CHEMICAL STRUCTURE; CHINESE HAMSTER; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HYDROPHOBICITY; INTRACELLULAR TRANSPORT; LIPID MEMBRANE; NONHUMAN; PARTICLE SIZE; ZETA POTENTIAL;

ANIMALS; ASPARTIC ACID; BETA-GALACTOSIDASE; CHO CELLS; CRICETINAE; CRICETULUS; GENE TRANSFER TECHNIQUES; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LIPIDS; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS; RNA, SMALL INTERFERING;

EID: 66249094567     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32026     Document Type: Article

References (23)

1. Couzin J. Breakthrough of the year. Small RNAs make big splash. Science 2002;298:2296-2297.
2. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371-378.
3. Novina CD, Sharp PA. The RNAi revolution. Nature 2004; 309:1527-1528.
4. Mattick JS. The functional genomics of noncoding RNA. Science 2005;309:1570-1573.
5. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2:243-247.
6. Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002;20: 1006-1010.
7. Devroe E, Silver PA. Retrovirus-delivered siRNA. BMC Biotechnol 2002;2:15.
8. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003;327:761-766.
9. Sioud M, Sorensen DR. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 2003;312:1220-1225.
10. Layzer JM, McCaffrey AP, Tanner AK, Huang Z, Kay MA, Sullenger BA. In vivo activity of nuclease-resistant siRNAs. RNA 2004;10:766-771.
11. Spagnou S, Miller AD, Keller M. Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004;43:13348-13356.
12. Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci USA 2005;102:5679-5684.
13. Hassani Z, Lemkine GF, Erbacher P, Palmier K, Alfama G, Giovannangeli C, Behr JP, Demeneix BA. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels. J Gene Med 2005; 7:198-207.
14. Read ML, Singh S, Ahmed Z, Stevenson M, Briggs SS, Oup-icky D, Barrett LB, Spice R, Kendall M, Berry M, Preece JA, Logan A, Seymour LW. A versatile reducible polycation- based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res 2005;33:86.
15. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-2245.
16. Check E. Gene therapy put on hold as third child develops cancer. Nature 2005;433:561.
17. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, Teratani T, Namatame N, Yamamoto Y, Hanai K, Kato T, Sano A, Ochiya T. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 2005;102:12177-12182.
18. Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Dea-vers MT, Lopez-Berestein G, Sood AK. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 2005;65:6910-6918.
19. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V, Vaish N, Zinnen S, Vargeese C, Bowman K, Shaffer CS, Jeffs LB, Judge A, MacLachlan I, Polisky B. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005;23:1002-1007.
20. Kunitake T, Okahata Y. A totally synthetic bilayer membrane. J Am Chem Soc 1977;99:3860-3871.
21. Kunitake T, Nakanishi N, Shimonura M, Okahata Y, Kano K, Ogawa T. Unique properties of chromophore-containing bilayer aggregates: Enhanced chirality and photochemically induced morphological change. J Am Chem Soc 1980;102:6642-6644.
22. Kunitake T. Organization and functions of synthetic bilayers. Ann NY Acad Sci 1986;471:70-82.
23. Opalinska JB, Gewirtz AM. Nucleic-acid therapeutics: Basic principles and recent applications. Nat Rev Drug Discov 2002;1:503-514.